Company Profiles

driven by the PitchBook Platform

AIKO Biotechnology

Description

Developer of drugs for pain management and opioid addiction. The company focuses on the discovery and validation of therapeutic compounds for the treatment of pain and the side effects associated with prescription opioid pain reliever use, such as opioid-induced bowel dysfunction, addiction and abuse.

2007

Founded

PRIVATE

Status

1-10

Employees

Series A

Latest Deal Type

$1.2M

Latest Deal Amount

$2.2M

Total Amount Raised

Description

Developer of drugs for pain management and opioid addiction. The company focuses on the discovery and validation of therapeutic compounds for the treatment of pain and the side effects associated with prescription opioid pain reliever use, such as opioid-induced bowel dysfunction, addiction and abuse.

Website:

www.aikobiotech.com

Ownership Status

Privately Held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Drug Discovery

Other Industries

Other Pharmaceuticals and Biotechnology
Pharmaceuticals

Primary Office

2 Union Street Suite 501 Portland, ME 04101United States
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore AIKO Biotechnology's full profile, request a free trial.

    AIKO Biotechnology Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    AIKO Biotechnology Investors (6)

    Request access
    Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
    Seat
    Contact
    Info
    Action EquityVenture CapitalMinority000 0000000 0000
    Individual InvestorAngel (individual)Minority000 0000000 0000
    Maine Technology InstituteOther000 0000000 0000
    Maine Venture FundVenture CapitalMinority000 0000000 0000
    National Institute on Drug Abuse (NIDA)Other000 0000000 0000
    Action Equity Venture Capital
    Individual Investor Angel (individual)
    Maine Technology Institute Other
    Maine Venture Fund Venture Capital
    National Institute on Drug Abuse (NIDA) Other

    AIKO Biotechnology Executive Team (2)

    NameTitleBoard
    Seat
    Contact
    Info
    Wolfgang SadeeCo-Founder, Chief Scientific Officer & Board Member
    Brian DallaireClinical Director
    Wolfgang Sadee Co-Founder, Chief Scientific Officer & Board Member
    Brian Dallaire Clinical Director

    AIKO Biotechnology Board Members (3)

    NameRepresentingRoleSinceContact
    Info
    David Anderson Ph.DSupply Chain VenturesManaging Director000 0000
    Paul Goldenheim MDSelfBoard Member000 0000
    Wolfgang SadeeAIKO BiotechnologyCo-Founder, Chief Scientific Officer & Board Member000 0000
    David Anderson Ph.D Managing Director Supply Chain Ventures
    Paul Goldenheim MD Board Member Self
    Wolfgang Sadee Co-Founder, Chief Scientific Officer & Board Member AIKO Biotechnology
    Request full access to PitchBook